Garrett-Mayer E - Search Results

1

Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death.

Guest ST, Kratche ZR, Irish JC, Wilson RC, Haddad R, Gray JW, Garrett-Mayer E, Ethier SP. Guest ST, et al. Oncotarget. 2016 Jun 14;7(24):36138-36153. doi: 10.18632/oncotarget.9147. Oncotarget. 2016. PMID: 27153554 Free PMC article.

2

KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.

Turner-Ivey B, Guest ST, Irish JC, Kappler CS, Garrett-Mayer E, Wilson RC, Ethier SP. Turner-Ivey B, et al. Neoplasia. 2014 Aug;16(8):644-55. doi: 10.1016/j.neo.2014.07.007. Neoplasia. 2014. PMID: 25220592 Free PMC article.

3

Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer.

Kappler CS, Guest ST, Irish JC, Garrett-Mayer E, Kratche Z, Wilson RC, Ethier SP. Kappler CS, et al. Mol Oncol. 2015 Feb;9(2):527-43. doi: 10.1016/j.molonc.2014.10.006. Epub 2014 Oct 23. Mol Oncol. 2015. PMID: 25454348 Free PMC article.

4

Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells.

Morris J, Moseley VR, Cabang AB, Coleman K, Wei W, Garrett-Mayer E, Wargovich MJ. Morris J, et al. Oncotarget. 2016 Jun 7;7(23):35313-26. doi: 10.18632/oncotarget.9204. Oncotarget. 2016. PMID: 27167203 Free PMC article.

5

Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.

Kesarwani P, Chakraborty P, Gudi R, Chatterjee S, Scurti G, Toth K, Simms P, Husain M, Armeson K, Husain S, Garrett-Mayer E, Vasu C, Nishimura MI, Mehrotra S. Kesarwani P, et al. Oncotarget. 2016 Oct 25;7(43):69371-69383. doi: 10.18632/oncotarget.12674. Oncotarget. 2016. PMID: 27750220 Free PMC article.

6

The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.

Coaxum SD, Tiedeken J, Garrett-Mayer E, Myers J, Rosenzweig SA, Neskey DM. Coaxum SD, et al. Oncotarget. 2017 Apr 4;8(14):22991-23007. doi: 10.18632/oncotarget.14967. Oncotarget. 2017. PMID: 28160562 Free PMC article.

7

Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models.

Homer-Bouthiette C, Zhao Y, Shunkwiler LB, Van Peel B, Garrett-Mayer E, Baird RC, Rissman AI, Guest ST, Ethier SP, John MC, Powers PA, Haag JD, Gould MN, Smits BMG. Homer-Bouthiette C, et al. BMC Cancer. 2018 Dec 10;18(1):1233. doi: 10.1186/s12885-018-5109-8. BMC Cancer. 2018. PMID: 30526553 Free PMC article.

8

Development and implementation of the SUM breast cancer cell line functional genomics knowledge base.

Ethier SP, Guest ST, Garrett-Mayer E, Armeson K, Wilson RC, Duchinski K, Couch D, Gray JW, Kappler C. Ethier SP, et al. NPJ Breast Cancer. 2020 Jul 21;6:30. doi: 10.1038/s41523-020-0173-z. eCollection 2020. NPJ Breast Cancer. 2020. PMID: 32715085 Free PMC article.

9

Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis.

Moussa O, Ashton AW, Fraig M, Garrett-Mayer E, Ghoneim MA, Halushka PV, Watson DK. Moussa O, et al. Cancer Res. 2008 Jun 1;68(11):4097-104. doi: 10.1158/0008-5472.CAN-07-6560. Cancer Res. 2008. PMID: 18519668

10

ZEB1-responsive genes in non-small cell lung cancer.

Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, Helfrich BA, Garrett-Mayer E, Bunn PA, Drabkin HA. Gemmill RM, et al. Cancer Lett. 2011 Jan 1;300(1):66-78. doi: 10.1016/j.canlet.2010.09.007. Epub 2010 Oct 25. Cancer Lett. 2011. PMID: 20980099 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters